Evidence map›Paper›PMID 36536234›Full record

ArticleProbiotics and antimicrobial proteins2024

Probiotic Potential of Bacillus amyloliquefaciens Isolated from Tibetan Yaks.

Yuanyuan He, Feiran Li, Wenqian Zhang, Miao An, Aoyun Li, Yaping Wang, Yan Zhang, Muhammad Fakhar-E-Alam Kulyar, Mudassar Iqbal, Jiakui Li

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Nutrients · 2026
    Article
  4. Article
  5. Nutrients · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Yuanyuan HeCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China.
Feiran LiCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China.
Wenqian ZhangCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China.
Miao AnCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China.
Aoyun LiCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China.
Yaping WangCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China.
Yan ZhangCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China.
Muhammad Fakhar-E-Alam KulyarCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China.
Mudassar IqbalCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China.
Jiakui LiCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China. lijk210@mail.hzau.edu.cn.
Huazhong Agricultural University · CNTibet University · CN

Funding

Key Project of Tibet Autonomous Region XZ202001ZY0044N
6 · The paper itself

Abstract

The Tibetan livestock sector is now ailing from many infectious ailments brought on by harmful microorganisms. Therefore, this research aimed to assess the probiotic potential and safety of Bacillus amyloliquefaciens isolated from yaks in the Tibet area to provide upper-edge strain resources for probiotics development. The four strains isolated from the intestine of yaks had been identified as Bacillus amyloliquefaciens after the 16S rRNA sequence. The ethanol, bile salt, and acid tolerance revealed that the isolates had significant tolerance levels. The antibiotics susceptibility assay showed that the strains were sensitive to commonly used antibiotics, while the antibacterial assay prevented the isolates from outperforming five harmful bacteria in terms of antibacterial potency. Moreover, it was evident that strain BA5 had the strongest activity to scavenge hydroxyl radical and reduce power. According to the animal experiment, no apparent pathological change was observed in intestinal tissue sections. Furthermore, the strain had a positive effect on promoting the development of jejunal villi referred to its safety. Therefore, more research is required into the bacteriostatic and antioxidant capabilities of isolates in animal production.

Indexed as

Bacillus amyloliquefaciensProbioticsAnimalsAnti-Bacterial AgentsCattleRNA, Ribosomal, 16STibetAnti-Bacterial AgentsRNA, Ribosomal, 16SBacillus amyloliquefaciensIdentificationProbioticsTibetYaks

Identifiers

PMID36536234
OpenAlexW4312018259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.